Gianluca Pettiti
Gianluca Pettiti has become president of the biosciences business of Thermo Fisher Scientific's Life Sciences Solutions segment. Previously, he was the company's president in Greater China. He joined the firm in 2006 as senior manager of financial planning and analysis for Applied Biosystem's Europe, Middle East, and Africa region. He later became EMEA finance director and then president of Latin America operations at Life Technologies. Pettiti holds a master's degree in management and financial engineering from the Polytechnic University of Turin in Italy.
Clive Brown
Clive Brown's appointment as director of Oxford Nanopore Technologies ended on Jan. 25, the company said in a filing this week. He is the firm's chief technology officer. Brown was appointed as a company director in September 2017.
Anthony Mattacchione, Gerald Herman
Bruker said that Anthony Mattacchione will resign as chief financial officer and senior VP, effective Mar. 16, 2018. Mattacchione has accepted a position as CFO of Albany Molecular Research, commencing in April 2018. Gerald Herman, currently vice president and corporate controller at Bruker, will also serve as Bruker's principal accounting officer, effective immediately. Herman joined the firm in 2016 as VP and corporate controller. Prior to that, he served as corporate VP of clinical operations of Parexel from 2014 to February 2016, and before that, corporate VP of Parexel from 2008 to 2013. Herman has also served as VP-corporate controller of Presstek.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.